Andrographolide in atherosclerosis: integrating network pharmacology and in vitro pharmacological evaluation.

Shuai ShiXinyu JiJingjing ShiShuqing ShiFei SheQiuyan ZhangYu DongHanming CuiYuanhui Hu

Published in: Bioscience reports (2022)

We successfully predict AG's potential targets and pathways in atherosclerosis and illustrate the mechanism of action. AG may regulate NF-κB/CEBPB/PPARG signaling to alleviate atherosclerosis.

Keyphrases

cardiovascular disease
quantum dots
signaling pathway
highly efficient
oxidative stress
type diabetes
visible light